2008 Clinical Practice Guidelines - Canadian Diabetes Association

strict glycemic control. Obstet Gynecol. 2004;104:1021-1024.
119. Martínez-Frías ML, Frías JP, Bermejo E, et al. Pre-gestational
maternal body mass index predicts an increased risk of congenital
malformations in infants of mothers with gestational
diabetes. Diabet Med. 2005;22:775-781.
120. García-Patterson A, Erdozain L, Ginovart G, et al. In human
gestational diabetes mellitus congenital malformations are
related to pre-pregnancy body mass index and to severity of
diabetes. Diabetologia. 2004;47:509-514.
121. Weisz B, Shrim A, Homko CJ, et al. One hour versus two
hours postprandial glucose measurement in gestational diabetes:
a prospective study. J Perinatol. 2005;25:241-244.
122. Dornhorst A, Frost G.The principles of dietary management
of gestational diabetes: reflection on current evidence. J Hum
Nutr Diet. 2002;15:145-156.
123. Anderson K, Barbeau M-C, Blagrave P, et al. Recommendations
for nutrition best practice in the management of gestational
diabetes mellitus. Can J Diet Pract Res. 2006;67:206-208.
124. Bung P, Bung C, Artal R, et al. Therapeutic exercise for
insulin-requiring gestational diabetics: effects on the fetus –
results of a randomized prospective longitudinal study.
J Perinat Med. 1993;21:125-137.
125. McFarland MB, Langer O, Conway DL, et al. Dietary therapy
for gestational diabetes: how long is long enough? Obstet
Gynecol. 1999;93:978-982.
126. Hadden DR.When and how to start insulin treatment in gestational
diabetes: a UK perspective. Diabet Med. 2001;18:960-
964.
127. Rossi G, Somigliana E, Moschetta M, et al. Adequate timing
of fetal ultrasound to guide metabolic therapy in mild gestational
diabetes mellitus. Results from a randomized study.
Acta Obstet Gynecol Scand. 2000;79:649-654.
128. Kjos SL, Schaefer-Graf U, Sardesi S, et al. A randomized controlled
trial using glycemic plus fetal ultrasound parameters
versus glycemic parameters to determine insulin therapy in
gestational diabetes with fasting hyperglycemia. Diabetes Care.
2001;24:1904-1910.
129. Kremer CJ, Duff P. Glyburide for the treatment of gestational
diabetes. Am J Obstet Gynecol. 2004;190:1438-1439.
130. Langer O, Conway DL, Berkus MD, et al. A comparison of
glyburide and insulin in women with gestational diabetes mellitus.
N Engl J Med. 2000;343:1134-1138.
131. Chmait R, Dinise T, Moore T. Prospective observational study
to establish predictors of glyburide success in women with
gestational diabetes mellitus. J Perinatol. 2004;24:617-622.
132. Elliott BD, Schenker S, Langer O, et al. Comparative placental
transport of oral hypoglycemic agents in humans: a model
of human placental drug transfer. Am J Obstet Gynecol. 1994;
171:653-660.
133. Conway DL, Gonzales O, Skiver D. Use of glyburide for the
treatment of gestational diabetes: the San Antonio experience.
J Matern Fetal Neonatal Med. 2004;15:51-55.
134. Bertini AM, Silva JC,Taborda W, et al. Perinatal outcomes and
the use of oral hypoglycemic agents. J Perinat Med. 2005;
33:519-523.
135. Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide
and insulin for the management of gestational diabetes
in a large managed care organization. Am J Obstet Gynecol.
2005;193:118-124.
136. Rowan JA, Hague WM, Gao W, et al; MiG Trial Investigators.
Metformin versus insulin for the treatment of gestational diabetes.
N Engl J Med. 2008;358:2003-2015.
137. Schaefer-Graf UM, Hartmann R, Pawliczak J, et al.
Association of breast-feeding and early childhood overweight
in children from mothers with gestational diabetes mellitus.
Diabetes Care. 2006;29:1105-1107.
138. Stuebe AM, Rich-Edwards JW,Willett WC, et al. Duration of
lactation and incidence of type 2 diabetes. JAMA. 2005;294:
2601-2610.
139. Catalano PM, Drago NM, Amini SB. Longitudinal changes in
pancreatic beta-cell function and metabolic clearance rate of
insulin in pregnant women with normal and abnormal glucose
tolerance. Diabetes Care. 1998;21:403-408.
140. Ergin T, Lembet A, Duran H, et al. Does insulin secretion in
patients with one abnormal glucose tolerance test value
mimic gestational diabetes mellitus? Am J Obstet Gynecol.
2002;186:204-209.
141. Kjos SL, Peters RK, Xiang A, et al. Predicting future diabetes
in Latino women with gestational diabetes. Utility of early
postpartum glucose tolerance testing. Diabetes. 1995;44:586-
591.
142. Pallardo F, Herranz L, Garcia-Ingelmo T, et al. Early postpartum
metabolic assessment in women with prior gestational
diabetes. Diabetes Care. 1999;22:1053-1058.
143. O’Sullivan JB. Diabetes mellitus after GDM. Diabetes.
1991;40(suppl 2):131-135.
144. Kim C, Newton KM, Knopp RH. Gestational diabetes and the
incidence of type 2 diabetes: a systematic review. Diabetes
Care. 2002;25:1862-1868.
145. Kaufmann RC, Schleyhahn FT, Huffman DG, et al.
Gestational diabetes diagnostic criteria: long-term maternal
follow-up. Am J Obstet Gynecol. 1995;172:621-625.
146. Schaefer-Graf UM, Buchanan TA, Xiang AH, et al. Clinical
predictors for a high risk for the development of diabetes mellitus
in the early puerperium in women with recent gestational
diabetes mellitus. Am J Obstet Gynecol. 2002;186:751-756.
147. Järvelä IY, Juutinen J, Koskela P, et al. Gestational diabetes
identifies women at risk for permanent type 1 and type 2 diabetes
in fertile age: predictive role of autoantibodies. Diabetes
Care. 2006;29:607-612.
148. Dozio N, Beretta A, Belloni C, et al. Low prevalence of islet
autoantibodies in patients with gestational diabetes mellitus.
Diabetes Care. 1997;20:81-83.
149. Löbner K, Knopff A, Baumgarten A, et al. Predictors of postpartum
diabetes in women with gestational diabetes mellitus.
Diabetes. 2006;55:792-797.
150. Smirnakis KV, Chasan-Taber L,Wolf M, et al. Postpartum diabetes
screening in women with a history of gestational dia-
S179
DIABETES IN SPECIAL POPULATIONS